Director at U S Physical Therapy (NYSE: USPH) granted 2,306 shares

Rhea-AI Filing Summary

Harris Bernard A Jr reported acquisition or exercise transactions in this Form 4 filing.

U S Physical Therapy director Bernard A. Harris Jr. received a grant of 2,306 shares of common stock as a restricted stock award. The grant was made at a reported transaction price of $0.00 per share and increased his direct holdings to 20,914 shares.

These 2,306 restricted shares vest in stages under the company’s Amended and Restated 2003 Stock Incentive Plan: 1,153 shares on August 20, 2026, 576 shares on November 20, 2026, and 577 shares on March 6, 2027, if he remains a director on those dates.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Harris Bernard A Jr

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	2,306	$0.00	--

Holdings After Transaction: Common Stock — 20,914 shares (Direct, null)

Footnotes (1)

1. 5/19/2026 - Transaction price should have been reported as $0.00, not $61.61. Includes 2,306 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,153 shares on August 20, 2026, 576 shares on November 20, 2026 and 577 shares on March 6, 2027, if he is a director of the Company on those dates.

Key Figures

Restricted stock grant: 2,306 shares Transaction price: $0.00 per share Holdings after grant: 20,914 shares +3 more

6 metrics

Restricted stock grant 2,306 shares Common stock award to director on May 19, 2026

Transaction price $0.00 per share Corrected transaction price for the restricted stock grant

Holdings after grant 20,914 shares Total direct common stock held following the transaction

First vesting tranche 1,153 shares Restrictions lapse on August 20, 2026 if still a director

Second vesting tranche 576 shares Restrictions lapse on November 20, 2026 if still a director

Third vesting tranche 577 shares Restrictions lapse on March 6, 2027 if still a director

Key Terms

restricted stock, Amended and Restated 2003 Stock Incentive Plan, transaction price, common stock

4 terms

restricted stock financial

"Includes 2,306 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan."

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Amended and Restated 2003 Stock Incentive Plan financial

"Includes 2,306 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan."

transaction price financial

"Transaction price should have been reported as $0.00, not $61.61."

common stock financial

"Includes 2,306 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan."

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Harris Bernard A Jr

(Last) (First) (Middle)

3333 ALLEN PARKWAY #1709

(Street)

HOUSTON TEXAS 77019

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
U S PHYSICAL THERAPY INC /NV [ USPH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)
05/20/2026

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/19/2026		A		2,306	A	$0.00(1)	20,914(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. 5/19/2026 - Transaction price should have been reported as $0.00, not $61.61.

2. Includes 2,306 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,153 shares on August 20, 2026, 576 shares on November 20, 2026 and 577 shares on March 6, 2027, if he is a director of the Company on those dates.

Remarks:

This Form 4/A amends the Form 4 originally filed on May 20, 2026, solely to correct the transaction price reported in Column 4 of Table I. The transaction price was incorrectly reported as $61.61 per share and is corrected herein to $0.00 per share. No other changes are being made to the original filing.

	/s/ Kate Venturina, as attorney-in-fact	05/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did U S Physical Therapy (USPH) director Bernard A. Harris Jr. report on this Form 4/A?

He reported receiving 2,306 shares of U S Physical Therapy common stock as a restricted stock award, at a transaction price of $0.00 per share, increasing his direct holdings to 20,914 shares, subject to future vesting conditions tied to continued board service.

How many U S Physical Therapy (USPH) shares were granted in this director award?

The award covers 2,306 shares of U S Physical Therapy common stock as restricted stock. These shares do not fully vest immediately and are subject to a staged vesting schedule through 2027, contingent on Bernard A. Harris Jr. continuing to serve as a director.

What is the vesting schedule for the 2,306 restricted shares reported for USPH?

The 2,306 restricted shares vest in three tranches: 1,153 shares on August 20, 2026, 576 shares on November 20, 2026, and 577 shares on March 6, 2027, provided Bernard A. Harris Jr. is still a director on each respective vesting date.

What are Bernard A. Harris Jr.’s total U S Physical Therapy (USPH) holdings after this grant?

Following the grant, he directly holds 20,914 shares of U S Physical Therapy common stock. This total includes the 2,306 restricted shares granted under the company’s Amended and Restated 2003 Stock Incentive Plan, which vest over time if board service continues.

Was the transaction price for the USPH restricted stock grant corrected in this Form 4/A?

Yes. A footnote states the transaction price should have been reported as $0.00 per share, not $61.61. This clarifies that the 2,306 shares were issued as a restricted stock award rather than a market purchase at a stated cash price.

Under what plan were the USPH restricted shares granted to director Bernard A. Harris Jr.?

The 2,306 restricted shares were granted under U S Physical Therapy’s Amended and Restated 2003 Stock Incentive Plan. This plan provides for equity-based awards, and the restrictions on these shares lapse on specified future dates if he remains a company director.